RC-1291 HCl

RC-1291 hydrochloride · Helsinn Therapeutics (U.S.), Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for RC-1291 HCl, covering 2013-09-02 to 2013-09-02. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy of RC-1291 HCl in Patients With Cancer Related Anorexia and Weight Loss [Phase 2]